dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | González-Martínez, Silvia |
dc.contributor.author | Pizarro, David |
dc.contributor.author | Pérez-Mies, Belén |
dc.contributor.author | Caniego-Casas, Tamara |
dc.contributor.author | Cortés Castan, Javier |
dc.contributor.author | Palacios, José |
dc.contributor.author | Curigliano, Giuseppe |
dc.date.accessioned | 2022-06-07T07:58:39Z |
dc.date.available | 2022-06-07T07:58:39Z |
dc.date.issued | 2021-10-28 |
dc.identifier.citation | González-Martínez S, Pizarro D, Pérez-Mies B, Caniego-Casas T, Curigliano G, Cortés J, et al. Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis. Cancers. 2021 Oct 28;13(21):5416. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7630 |
dc.description | Càncer de mama; Metàstasi; Pell |
dc.description.sponsorship | This review was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI19/01331) and CIBERONC (CB16/12/00316 and CB16/12/00449), co-financed by the European Development Regional Fund, ‘A way to achieve Europe’ (FEDER), and by the Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13(21) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Mama - Càncer - Prognosis |
dc.subject | Metàstasi |
dc.subject | Cèl·lules canceroses - Proliferació |
dc.subject.mesh | Breast Neoplasms |
dc.subject.mesh | Neoplasm Metastasis |
dc.subject.mesh | /pathology |
dc.title | Clinical, Pathological, and Molecular Features of Breast Carcinoma Cutaneous Metastasis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13215416 |
dc.subject.decs | neoplasias de la mama |
dc.subject.decs | metástasis neoplásica |
dc.subject.decs | /patología |
dc.relation.publishversion | https://doi.org/10.3390/cancers13215416 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [González-Martínez S] Clinical Researcher, Hospital Ramón y Cajal, Madrid, Spain. Fundación Contigo contra el Cáncer de la Mujer, Madrid, Spain. [Pizarro D, Caniego-Casas T] Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain. [Pérez-Mies B, Palacios J] Department of Pathology, Hospital Ramón y Cajal, Madrid, Spain. Institute Ramón y Cajal for Health Research (IRYCIS), Madrid, Spain. CIBER-ONC, Instituto de Salud Carlos III, Madrid, Spain. Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, Madrid, Spain. [Curigliano G] European Institute of Oncology, IRCCS, Milan, Italy. Departament of Oncology and Hematology, University of Milan, Milan, Italy. [Cortés J] CIBER-ONC, Instituto de Salud Carlos III, Madrid, Spain. Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain. Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain. International Breast Cancer Center (IBCC), Quironsalud Group, Barcelona, Spain. Medica Scientia Innovation Research, Barcelona, Spain. Medica Scientia Innovation Research, Ridgewood, NJ, USA. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34771579 |
dc.identifier.wos | 000719073300001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/CB16%2F12%2F00449 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |